Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
boston top stories
5
×
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicaid
5
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
5
×
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
national
cancer
medicare
bill &
cancer immunotherapy
clinical trials
deals
democrats
drug price
fda
investing
johnson & johnson
nancy pelosi
What
drug
plan
house
price
prices
roundup
year
agency
ahead
aimmune
allergy
alzheimer’s
ambien
american
anathema
annual
answer
approval
approved
asco
attendees
attention
awaited
awarded
away
bio
biotech
camp’s
cancer
cash
chicago
city
clinical
combinations
community’s
companies
days
democrat
democratic
dems
Language
unset
Current search:
medicaid
×
" boston top stories "
×
biotech
×
" san diego blog main "
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
4 years ago
After First Look at House Drug Plan, Stocks Rise Slightly
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More